Report title: Biogen, Inc. - Portfolio Company Report
from Thomson Financial Venture Economics
published May 16, 2009

Price $24.00 available for immediate download
Report Overview
 
About Thomson Financial Venture Econ...

Develops and manufactures human pharmaceuticals through genetic engineering. The Company's products include interferon Alfa-2B, which is an alpha interferon, a naturally occurring protein produced by normal white blood cells, used for the treatment of cancer. A second product is the hepatitis vaccine. Since the hepatitis B virus can be transmitted via human blood, the hepatitis B antigens, including core, surface and E antigens, can be used to detect infection by the hepatitis virus. The Company also develops CD4, also known as recombinant soluble T4, used for the treatment of AIDS. ; Develops pharmaceuticals for human healthcare through genetic engineering.

Report Type: This research report shows venture capital financing information for this specific company.
Executives Listed: 19
Number of Investing Funds: 11
Free Sample: Click Here to Download
Format:
PDF Adobe Acrobat


Price: $24.00



  Can't Decide?

Purchasing premium research sight unseen can be intimidating. At Alacra we want you to know what you are getting. Visit our FAQ or ask our Customer Service Team any questions about the report you are considering purchasing.